HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
OWLT
Owlet, Inc.
There isn't enough reported data to score OWLT yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
OWLT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Unavailable |
OWLT's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
OWLT PE Valuation
OWLT has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
OWLT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
OWLT has the edge over HIMS on the outlook, with more favorable earnings and profitability expectations.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
OWLT has the stronger earnings trend. Trailing diluted EPS is down 257% for HIMS versus OWLT down 234%.
OWLT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2025 | -$3.20 | -$0.82 |
| Q2 2025 | -$3.75 | -$1.14 |
| Q1 2025 | -$1.68 | +$1.82 |
| Q4 2024 | -$2.30 | +$2.23 |
| Q3 2024 | -$2.38 | +$3.57 |
| Q2 2024 | -$2.61 | +$4.88 |
| Q1 2024 | -$3.50 | +$4.34 |
| Q4 2023 | -$4.53 | +$5.41 |
OWLT is still losing money, but far less than before: $3.20 per share over the past year, against $13.28 at its worst in mid-2022.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over OWLT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
OWLT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $33.9M | +30% |
| Q1 2026 | $22.5M | +6.4% |
| Q4 2025 | $26.6M | +30% |
| Q3 2025 | $32M | +45% |
| Q2 2025 | $26.1M | +26% |
| Q1 2025 | $21.1M | +43% |
| Q4 2024 | $20.5M | -2.5% |
| Q3 2024 | $22.1M | +141% |
OWLT's revenue has grown year over year for six quarters in a row: $34M last quarter, up 30% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 5.1% | +13 points |
| Q1 2026 | -24% | -12 points |
| Q4 2025 | -18% | +18 points |
| Q3 2025 | 3.8% | +26 points |
| Q2 2025 | -7.4% | +3.5 points |
| Q1 2025 | -13% | +26 points |
| Q4 2024 | -36% | -22 points |
| Q3 2024 | -22% | +64 points |
OWLT has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over OWLT on cash generation, producing positive trailing cash flow while its opponent burns cash.
OWLT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$631K | +$1.7M |
| Q1 2026 | -$5.1M | +$865K |
| Q4 2025 | -$651K | -122% |
| Q3 2025 | -$2.2M | +$5.7M |
| Q2 2025 | -$2.3M | +$1M |
| Q1 2025 | -$5.9M | -$2.6M |
| Q4 2024 | $3M | +$4.6M |
| Q3 2024 | -$7.9M | -$2.7M |
OWLT has burned cash in almost every quarter: −$9M over the past year, against −$13M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over OWLT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
OWLT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.4% | +950K shares |
| 1 year | +85% | +13.1M shares |
| 3 years | +252% | +20.4M shares |
| 5 years | +1289% | +26.5M shares |
OWLT has 29M diluted shares, up 85% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2021 | — |
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
OWLT Net Leverage
OWLT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
OWLT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.1 | Neutral |
| Stochastic | 9.3 | Oversold |
OWLT's weekly RSI is 43 (neutral) and its Stochastic is 9 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
OWLT PE vs Healthcare Sector
OWLT has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
OWLT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.49 | 2.9% above |
| 20 week MA | $5.02 | 8% below |
| 50 week MA | $7.32 | 37% below |
| 100 week MA | $6.92 | 33% below |
| 200 week MA | $5.77 | 20% below |
OWLT has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over OWLT on returns for 2026, with the stronger performance.
OWLT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $135.8 | $140.8 | +3.7% |
| 2021 | $140.8 | $40.7 | -71% |
| 2022 | $40.7 | $9.57 | -77% |
| 2023 | $9.57 | $5.28 | -45% |
| 2024 | $5.28 | $4.48 | -15% |
| 2025 | $4.48 | $15.5 | +247% |
| 2026 YTD | $15.5 | $4.62 | -70% |
OWLT's yearly returns have swung widely, from +247% in 2025 to −77% in 2022. It's down 70% so far in 2026.